BTL-MK
BTL-MK (Compound 19) an orally active antiallergic agent, that inhibits degranulation of mast cells with an IC50 of 6.7 μM, through binding to the inhibitory receptor FcγRIIB. BTL-MK improves the metaboilic stability in human liver microsomes. BTL-MK ameliorates the allergic response in Ovalbumins -induced food allergy mice model. BTL-MK exhibits a good pharmacokinetic character with metabolic stability[1].
Product Specifications
CAS Number
2758569-43-4
UNSPSC
12352005
Target
Fc Receptor (FcR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/btl-mk.html
Solubility
10 mM in DMSO
Smiles
OC1=CC=C(C=C1C/C=C(C)\C)C[C@]2(OC(C(O)=C2C3=CC=C(C=C3)O)=O)C(C)=O
Molecular Formula
C24H24O6
Molecular Weight
408.44
References & Citations
[1]Xie CL, et al., Lead Optimization of Butyrolactone I as an Orally Bioavailable Antiallergic Agent Targeting FcγRIIB. J Med Chem. 2024 May 9;67 (9) :7504-7515.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY400060 100 µg
Gastric Inhibitory Polypeptide Receptor (GIPR) (NM_000164) Human Over-expression Lysate
Sign In for Pricing
View Details 
